TrialThe oncologist2017

A Phase II Multi-Center Study of Bevacizumab in Combination with Ixabepilone in Subjects with Advanced Renal Cell Carcinoma.

Mauricio Burotto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.